Source assessmentCore
Autonomous Surgical Robots: The Malpractice-Product Liability Boundary
Autonomous surgical robots liabilityAcademic
Assessment outcome
total 5/6 (actionability 1 + authority 2 + currency 2)
Total5/6
Actionability1/2
Authority2/2
Currency2/2
Authorship & scope
Attribution (G4 evidence)
No evidence recorded for this source.
Issuer authority (evidence)
No evidence recorded for this source.
Issuers, who it governs, legal force and content are on the full record.
Eligibility gates
G1 · Retrievablepass
Passed in screening.
G2 · AI nexuspass
Passed in screening.
G3 · Governance nexuspass
Passed in screening.
G4 · Attributablepass
Passed in screening.
G5 · In forcepass
Passed in screening.
Scored criteria
Actionability
1/2No rationale recorded.
Where clinicians retain effective control over the relevant clinical risk, malpractice should remain the primary liability regime. Where harm arises from hardware, software, algorithms, warnings, or autonomous behavior that clinicians could not reasonably detect or control, product-side liability should gain greater weight.
Authority
2/2No rationale recorded.
All submissions undergo an editorial screening followed by double-blind peer review prior to publication.
Currency
2/2No rationale recorded.
Classification
Coverage topicAutonomous surgical robots liability
PerspectiveAcademic
Lifecycle stage7 Use & impact
Layerboth
GranularityNot recorded